Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akifumi Tokita

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 1, 2002
[The study of the genetics of osteoporosis]Akifumi Tokita
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 18, 2003
[Genetic factors of osteoporosis and polymorphisms]Akifumi Tokita
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 23, 2002
[Bone disease with vitamin D receptor abnormality]Akifumi Tokita, Ken Hisada, Kyoko Nishizawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 24, 2004
[Genetic study of osteoporosis]Akifumi Tokita, Ken Hisata, Kyoko Nishizawa
Clinical Calcium|March 19, 2005
[Dietary calcium and VDR gene polymorphism's interaction]Ken Hisada, Kyoko Nishizawa, Akifumi Tokita
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 24, 2004
[Type I collagen gene polymorphism]Ken Hisata, Kyoko Nishizawa, Atushi Unno, et al.
The Journal of Obstetrics and Gynaecology Research|March 11, 2004
Association of bone mineral density with vitamin D and estrogen receptor gene polymorphisms during GnRH agonist treatmentMasami Seko, Hiroyuki Takeuchi, Katsuyuki Kinoshita, et al.
Journal of Bone and Mineral Metabolism|May 2, 2002
Association of gene polymorphisms and bone density in Japanese girlsKiyoe Katsumata, Kyoko Nishizawa, Atsushi Unno, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|June 26, 2007
Serum free T4 and thyroid stimulating hormone levels in preterm infants and relationship between these levels and respiratory distress syndromeKyoko Tanaka, Toshiaki Shimizu, Atsuto Hosaka, et al.
Calcified Tissue International|October 2, 2009
Minimum required vitamin D level for optimal increase in bone mineral density with alendronate treatment in osteoporotic womenMuneaki Ishijima, Yuko Sakamoto, Makoto Yamanaka, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 1, 2002
[The study of the genetics of osteoporosis]Akifumi Tokita
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 18, 2003
[Genetic factors of osteoporosis and polymorphisms]Akifumi Tokita
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 23, 2002
[Bone disease with vitamin D receptor abnormality]Akifumi Tokita, Ken Hisada, Kyoko Nishizawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 24, 2004
[Genetic study of osteoporosis]Akifumi Tokita, Ken Hisata, Kyoko Nishizawa
Clinical Calcium|March 19, 2005
[Dietary calcium and VDR gene polymorphism's interaction]Ken Hisada, Kyoko Nishizawa, Akifumi Tokita
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 24, 2004
[Type I collagen gene polymorphism]Ken Hisata, Kyoko Nishizawa, Atushi Unno, et al.
The Journal of Obstetrics and Gynaecology Research|March 11, 2004
Association of bone mineral density with vitamin D and estrogen receptor gene polymorphisms during GnRH agonist treatmentMasami Seko, Hiroyuki Takeuchi, Katsuyuki Kinoshita, et al.
Journal of Bone and Mineral Metabolism|May 2, 2002
Association of gene polymorphisms and bone density in Japanese girlsKiyoe Katsumata, Kyoko Nishizawa, Atsushi Unno, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|June 26, 2007
Serum free T4 and thyroid stimulating hormone levels in preterm infants and relationship between these levels and respiratory distress syndromeKyoko Tanaka, Toshiaki Shimizu, Atsuto Hosaka, et al.
Calcified Tissue International|October 2, 2009
Minimum required vitamin D level for optimal increase in bone mineral density with alendronate treatment in osteoporotic womenMuneaki Ishijima, Yuko Sakamoto, Makoto Yamanaka, et al.
Pageof 3